Universal Beteiligungs und Servicegesellschaft mbH Purchases Shares of 19,208 DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Key Points

• Universal Beteiligungs und Servicegesellschaft mbH has taken a new position in DENTSPLY SIRONA Inc., purchasing 19,208 shares valued at approximately $287,000 during the first quarter.
• DENTSPLY SIRONA recently announced a quarterly dividend of $0.16, reflecting a 4.5% dividend yield, with a payout ratio of -14.10%.
• The stock has experienced significant activity from institutional investors, with 95.70% of its stock currently held by such entities.

Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 19,208 shares of the medical instruments supplier's stock, valued at approximately $287,000.

Other hedge funds have also added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of DENTSPLY SIRONA in the 1st quarter worth approximately $25,000. Colonial Trust Co SC bought a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth approximately $26,000. True Wealth Design LLC raised its holdings in shares of DENTSPLY SIRONA by 866.7% in the 4th quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier's stock worth $41,000 after purchasing an additional 1,950 shares during the period. Allworth Financial LP raised its holdings in DENTSPLY SIRONA by 175.8% during the 1st quarter. Allworth Financial LP now owns 3,949 shares of the medical instruments supplier's stock valued at $54,000 after acquiring an additional 2,517 shares during the period. Finally, Quarry LP raised its holdings in DENTSPLY SIRONA by 25.7% during the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock valued at $72,000 after acquiring an additional 780 shares during the period. Institutional investors and hedge funds own 95.70% of the company's stock.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock traded down $0.37 during trading hours on Wednesday, reaching $13.68. The company's stock had a trading volume of 5,608,192 shares, compared to its average volume of 2,913,575. The stock has a market cap of $2.73 billion, a P/E ratio of -3.01, a P/E/G ratio of 1.02 and a beta of 0.94. DENTSPLY SIRONA Inc. has a one year low of $12.16 and a one year high of $27.48. The firm has a 50 day moving average price of $15.89 and a 200-day moving average price of $16.02. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.10 and a quick ratio of 0.76.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, topping analysts' consensus estimates of $0.29 by $0.14. The business had revenue of $879.00 million for the quarter, compared to the consensus estimate of $854.75 million. DENTSPLY SIRONA had a negative net margin of 24.42% and a positive return on equity of 14.31%. The company's revenue for the quarter was down 7.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.42 EPS. On average, analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, July 11th. Investors of record on Friday, June 27th were given a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, June 27th. This represents a $0.64 dividend on an annualized basis and a yield of 4.7%. DENTSPLY SIRONA's dividend payout ratio is presently -14.10%.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the stock. Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a research report on Monday, July 21st. Piper Sandler lowered their price objective on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a research note on Wednesday, April 30th. Wall Street Zen raised shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Sunday, July 13th. Morgan Stanley downgraded shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price for the company. in a research note on Tuesday, April 15th. Finally, UBS Group cut their price target on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating on the stock in a report on Friday, May 9th. Ten equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $19.60.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.